Assessment of Cognition and Quality of Life in Non-Hodgkin’s Lymphoma Patients One Year Post-Treatment
Journal Title: Journal of Clinical Research & Bioethics - Year 2017, Vol 8, Issue 3
Abstract
Objectives: An increasing number of patients with cancer are offered chemotherapy given either alone or in combination with radiotherapy, surgery, or both as neo-adjuvant, concomitant, or adjuvant treatment. Cognitive dysfunction is a prevalent side effect of cancer treatments that may persist for years following treatment and has negative impact on quality of life. Thus, the present study was planned to investigate the prevalence of cognitive impairment, assess the quality of life (QOL) and determine the socioeconomic status in NHL patients one year post chemotherapy treatment. Methods: This was an observational study. All the prospective participants were screened on the basis of inclusion and exclusion criteria and the participants who met all the study inclusion criteria and had none of the exclusion criteria were enrolled in the study. Cognitive function was evaluated using Mini Mental State Examination (MMSE) or Hindi Mental State Examination (HMSE), socioeconomic status was determined by Kuppuswamy scale and quality of life (QoL) was assessed by EORTC QLQ. Results: A total of 90 subjects (45 cases and 45 controls) were enrolled in the study. The control group scored more on MMSE/HMSE scale than the Non-Hodgkin’s Lymphoma (NHL) patient group, suggesting difference in cognitive functioning between the groups (26.6 ± 2.4 vs. 27.8 ± 2.1, p=0.019), respectively. Socio-economic status did not have any impact on the prevalence of cognitive impairment in NHL patients; however, NHL was found to be more prevalent in upper-middle class. No significant difference was found between case and control for QoL. Conclusion: Cognitive dysfunction is a prevalent side effect of cancer treatment that may persist for a year following treatment. Further studies are needed to clarify the effect on quality of life
Authors and Affiliations
Pooja Gupta, Sakshi Mittal, Nidhi B Agarwal, Rizwana Parveen
Keywords
Related Articles
- EP ID EP358651
- DOI 10.4172/2155-9627.1000302
- Views 60
- Downloads 0
The Horns of Dilemma: Life or Sovereignty?
Death and dying are the bitter truth that is faced by every person inevitably. Paying respect to the decision of a patient in a hospital setting is always a challenging task. In eastern countries, family plays an importa...
Ethical Issues in Patients with Leukemia: Practice Points and Educational Topics for the Clinical Oncologist and Trainees
Leukemia represents a complex spectrum of malignancies, involving numerous treatment options and substantial symptom burden for patients. Ethical dilemmas may arise which challenge a physician's clinical management and t...
Editor’s Note: Journal of Clinical Research & Bioethics (Volume 8 Issue 2)
The Journal of Clinical Research & Bioethics is dedicated to publishing the latest views and guidelines in Bioethics. The current issue of the Journal of Clinical Research & Bioethics presents some interesting thoughts p...
A Commentary on Laughter Therapy
My article “El poder terapeutico de la risa” (The therapeutic power of laughter) was published in 2015 in the journal ‘Bioethics Update’ 1(2): 130-142 and was the most read of that journal in 2015 (560 downloads). It add...
Amnestic MCI Patients’ Perspectives on Volunteer Participation in a Research Context
Background: Inclusion of patients in research studies is immensely important when evaluating new biomarkers for Alzheimer’s disease (AD) and when the efficacy of possible treatment options is under trial investigation. I...